Use of hepatobiliary phase images in Gd-EOB-DTPA-enhanced MRI of breast cancer hepatic metastasis to predict response to chemotherapy
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Hyun Ji | - |
dc.contributor.author | Lee, Chang Hee | - |
dc.contributor.author | Kim, Jeong Woo | - |
dc.contributor.author | Park, Yang Shin | - |
dc.contributor.author | Lee, Jongmee | - |
dc.contributor.author | Kim, Kyeong Ah | - |
dc.date.available | 2020-11-02T08:42:28Z | - |
dc.date.issued | 2017-05 | - |
dc.identifier.issn | 0899-7071 | - |
dc.identifier.issn | 1873-4499 | - |
dc.identifier.uri | https://scholarworks.korea.ac.kr/kumedicine/handle/2020.sw.kumedicine/5079 | - |
dc.description.abstract | Objectives: To determine the prognostic value of Gd-EOB-DTPA MRI findings of liver metastasis from breast cancer. Methods: 29 metastatic lesions from 12 breast cancer patients who received chemotherapy were retrospectively reviewed. We evaluated hepatobiliary phase of the lesions and classified them as a "target" or "non-target" appearance. The relationship of appearance or SI ratio with tumor response was analyzed. Results: A non-target appearance was more frequent in disease control group than in non-control group [14/18 (77.8%) vs. 4/18 (222%)], and it was associated with a better response [p = 0.048]. Conclusion: HBP analysis may be useful to predict the response to chemotherapy and survival. (C) 2017 Elsevier Inc. All rights reserved. | - |
dc.format.extent | 5 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | ELSEVIER SCIENCE INC | - |
dc.title | Use of hepatobiliary phase images in Gd-EOB-DTPA-enhanced MRI of breast cancer hepatic metastasis to predict response to chemotherapy | - |
dc.type | Article | - |
dc.publisher.location | 미국 | - |
dc.identifier.doi | 10.1016/j.clinimag.2017.03.005 | - |
dc.identifier.scopusid | 2-s2.0-85014990382 | - |
dc.identifier.wosid | 000401298400025 | - |
dc.identifier.bibliographicCitation | CLINICAL IMAGING, v.43, pp 127 - 131 | - |
dc.citation.title | CLINICAL IMAGING | - |
dc.citation.volume | 43 | - |
dc.citation.startPage | 127 | - |
dc.citation.endPage | 131 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Radiology, Nuclear Medicine & Medical Imaging | - |
dc.relation.journalWebOfScienceCategory | Radiology, Nuclear Medicine & Medical Imaging | - |
dc.subject.keywordPlus | PROGNOSTIC-FACTORS | - |
dc.subject.keywordPlus | LIVER-LESIONS | - |
dc.subject.keywordPlus | THERAPY | - |
dc.subject.keywordPlus | INFILTRATION | - |
dc.subject.keywordPlus | SURVIVAL | - |
dc.subject.keywordPlus | TARGET | - |
dc.subject.keywordAuthor | Gadoxetic acid | - |
dc.subject.keywordAuthor | MRI | - |
dc.subject.keywordAuthor | Hepatobiliary phase (HBP) | - |
dc.subject.keywordAuthor | Breast cancer liver metastases | - |
dc.subject.keywordAuthor | Chemotherapy response | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
73, Goryeodae-ro, Seongbuk-gu, Seoul, Republic of Korea (02841)82-2-2286-1265
COPYRIGHT 2020 KOREA UNIVERSITY MEDICAL LIBRARY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.